Aroa Biosurgery Limited (AROAF)
OTCMKTS · Delayed Price · Currency is USD
0.3500
0.00 (0.00%)
Aug 1, 2025, 4:00 PM EDT
Aroa Biosurgery Revenue
In the fiscal year ending March 31, 2025, Aroa Biosurgery had annual revenue of 84.70M NZD with 22.63% growth. Aroa Biosurgery had revenue of 45.54M in the half year ending March 31, 2025, with 33.85% growth.
Revenue
84.70M NZD
Revenue Growth
+22.63%
P/S Ratio
2.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
142.50M USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 84.70M | 15.63M | 22.63% |
Mar 31, 2024 | 69.07M | 5.71M | 9.01% |
Mar 31, 2023 | 63.36M | 23.68M | 59.68% |
Mar 31, 2022 | 39.68M | 17.34M | 77.60% |
Mar 31, 2021 | 22.34M | -2.73M | -10.90% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |